Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Phase 2 Proof-of-concept Pilot Trial of Topical Ruxolitinib in Repigmenting Adult Patients With Vitiligo

NCT02809976 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT02809976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02809976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Phase 2 Proof-of-concept Pilot Trial of Topical Ruxolitinib in Repigmenting Adult Patients With Vitiligo
Lead sponsor
Tufts Medical Center
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2016
Completion date
February 28, 2017
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo